Literature DB >> 25986481

Anemia and splenomegaly: what lies behind?

Margherita Migone De Amicis1, Bruno Fattizzo, Erika Poggiali, Francesca Minonzio, Umberto Gianelli, Maria Domenica Cappellini.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25986481     DOI： 10.1007/s11739-015-1254-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  10 in total

1.  An unusual pulmonary mass with mediastinal invasion and multiple intrapulmonary nodules in a 52-year-old man.

Authors:  Chih-Jen Yang; Jui-Ying Lee; Chun-Chieh Wu; Hsin-Ling Yin; Chi-Tun Lien; Yi-Chang Liu
Journal:  Chest       Date:  2012-01       Impact factor: 9.410

2.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

3.  Langerhans cell sarcoma emanating from the upper arm skin: successful treatment by MAID regimen.

Authors:  Kenzo Uchida; Shigeru Kobayashi; Tomoo Inukai; Sakon Noriki; Yoshiaki Imamura; Hideaki Nakajima; Takafumi Yayama; Norbert Orwotho; Hisatoshi Baba
Journal:  J Orthop Sci       Date:  2008-02-16       Impact factor: 1.601

4.  BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease.

Authors:  Maria Giulia Cangi; Riccardo Biavasco; Giulio Cavalli; Greta Grassini; Elena Dal-Cin; Corrado Campochiaro; Barbara Guglielmi; Alvise Berti; Vito Lampasona; Andreas von Deimling; Maria Grazia Sabbadini; Marina Ferrarini; Claudio Doglioni; Lorenzo Dagna
Journal:  Ann Rheum Dis       Date:  2014-03-26       Impact factor: 19.103

5.  Langerhans cell sarcoma.

Authors:  Tammie Ferringer; Peter M Banks; John S Metcalf
Journal:  Am J Dermatopathol       Date:  2006-02       Impact factor: 1.533

6.  CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 cases.

Authors:  Takakazu Kawase; Minoru Hamazaki; Michinori Ogura; Yoshiaki Kawase; Toshihiko Murayama; Yoshio Mori; Hirokazu Nagai; Masatoshi Tateno; Takashi Oyama; Yoshikazu Kamiya; Hirofumi Taji; Yoshitoyo Kagami; Tomoki Naoe; Toshitada Takahashi; Yasuo Morishima; Shigeo Nakamura
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

Review 7.  Erdheim-Chester disease: characteristics and management.

Authors:  Javier Munoz; Filip Janku; Philip R Cohen; Razelle Kurzrock
Journal:  Mayo Clin Proc       Date:  2014-05-09       Impact factor: 7.616

8.  Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.

Authors:  S A Pileri; T M Grogan; N L Harris; P Banks; E Campo; J K C Chan; R D Favera; G Delsol; C De Wolf-Peeters; B Falini; R D Gascoyne; P Gaulard; K C Gatter; P G Isaacson; E S Jaffe; P Kluin; D M Knowles; D Y Mason; S Mori; H-K Müller-Hermelink; M A Piris; E Ralfkiaer; H Stein; I-J Su; R A Warnke; L M Weiss
Journal:  Histopathology       Date:  2002-07       Impact factor: 5.087

Review 9.  Langerhans cell sarcoma in the cervical lymph node: a case report and literature review.

Authors:  Yi-ni Wang; Xiao-ge Zhou; Zhao Wang
Journal:  Acta Haematol       Date:  2012-11-27       Impact factor: 2.195

10.  ESHAP therapy effective in a patient with Langerhans cell sarcoma.

Authors:  Akihide Yoshimi; Keiki Kumano; Toru Motokura; Yutaka Takazawa; Satoshi Oota; Shigeru Chiba; Tsuyoshi Takahashi; Masashi Fukayama; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2008-04-17       Impact factor: 2.490
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.